Gene therapy clinical trials worldwide to 2017: An update

  • Samantha L. Ginn
    Gene Therapy Research Unit, Children's Medical Research Institute The University of Sydney and The Sydney Children's Hospitals Network Westmead NSW Australia
  • Anais K. Amaya
    Gene Therapy Research Unit, Children's Medical Research Institute The University of Sydney and The Sydney Children's Hospitals Network Westmead NSW Australia
  • Ian E. Alexander
    Gene Therapy Research Unit, Children's Medical Research Institute The University of Sydney and The Sydney Children's Hospitals Network Westmead NSW Australia
  • Michael Edelstein
    Centre on Global Health Security Chatham House London UK
  • Mohammad R. Abedi
    Department of Laboratory Medicine Uppsala University Hospital Uppsala Sweden

説明

<jats:title>Abstract</jats:title><jats:p>To date, almost 2600 gene therapy clinical trials have been completed, are ongoing or have been approved worldwide. Our database brings together global information on gene therapy clinical activity from trial databases, official agency sources, published literature, conference presentations and posters kindly provided to us by individual investigators or trial sponsors. This review presents our analysis of clinical trials that, to the best of our knowledge, have been or are being performed worldwide. As of our November 2017 update, we have entries on 2597 trials undertaken in 38 countries. We have analysed the geographical distribution of trials, the disease indications (or other reasons) for trials, the proportions to which different vector types are used, and the genes that have been transferred. Details of the analyses presented, and our searchable database are available via <jats:italic>The Journal of Gene Medicine</jats:italic> Gene Therapy Clinical Trials Worldwide website at: <jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.wiley.co.uk/genmed/clinical">http://www.wiley.co.uk/genmed/clinical</jats:ext-link>. We also provide an overview of the progress being made in gene therapy clinical trials around the world, and discuss key trends since the previous review, namely the use of chimeric antigen receptor T cells for the treatment of cancer and advancements in genome editing technologies, which have the potential to transform the field moving forward.</jats:p>

収録刊行物

被引用文献 (15)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ